<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0021">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Widjaja</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>van Haperen</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gutiérrez-Álvarez</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>van Dieren</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Okba</surname>
    <given-names>NMA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Raj</surname>
    <given-names>VS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fernandez-Delgado</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Grosveld</surname>
    <given-names>F</given-names>
   </name>, et al
  </person-group>
  <article-title>Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein</article-title>. 
  <source>Emerging Microbes Infect</source>. 
  <year>2019</year>;
  <volume>8</volume>(
  <issue>1</issue>):
  <fpage>516</fpage>–
  <lpage>30</lpage>. doi:
  <pub-id pub-id-type="doi">10.1080/22221751.2019.1597644</pub-id>.
 </mixed-citation>
</ref>
